Medication info
Twin Plus Tablet 40/10mg

Twin Plus Tablet 40/10mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu X 3], 30 tablets/bottle
Approval status
Active

MFDS item code 201702159 · Approved 2017.04.27 · Insurance code 660703080

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan); however, an immediate switch to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In older adults aged 75 years or older, amlodipine clearance is decreased; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
Pediatric patients aged 18 years or younger: The safety and efficacy have not been established; therefore, administration of this drug is not recommended.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Medications such as Amlodipine or Telmisartan are helpful in effectively lowering blood pressure in patients whose hypertension is not well controlled with single-agent therapy. These medications are used to manage essential hypertension and reduce the risk of cardiovascular complications. Therefore, they are suitable for individuals facing difficulties in blood pressure control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan); however, an immediate switch to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In older adults aged 75 years or older, amlodipine clearance is decreased; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

Pediatric patients aged 18 years or younger: The safety and efficacy have not been established; therefore, administration of this drug is not recommended.

Precautions

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. This medication should not be given to patients with certain conditions, such as severe liver impairment, hypotension, outflow obstruction of the heart, or unstable heart failure following acute myocardial infarction. Special caution is required when using this medication in patients with conditions such as primary aldosteronism or heart valve disease, liver impairment, gastrointestinal diseases, renal artery hypertension, patients on dialysis for renal failure, and the elderly. Common side effects may include dizziness and peripheral edema, and in rare cases, severe side effects such as syncope or myocardial infarction may occur; thus, if any unusual symptoms arise, immediate consultation with healthcare providers is necessary. Use of this medication during pregnancy can result in decreased renal function in the fetus, reduction of amniotic fluid, and delayed skull formation; therefore, it should be discontinued immediately once pregnancy is confirmed. Lactating women are advised not to use this medication, and they should consult a physician if necessary. Safety and efficacy in pediatric patients under 18 years of age have not been sufficiently established, so its use is not recommended. In elderly patients, sensitivity to the drug response may be heightened; thus, it is advisable to start at a lower dose and gradually increase the dosage. Overdose may result in symptoms such as hypotension, dizziness, or impaired heart function, requiring immediate medical attention. This medication can interact with others, so it is crucial to inform healthcare providers of any other medications being taken. Dizziness or drowsiness may occur when driving or operating machinery; therefore, caution is advised. Keep this medication out of the reach of children and store it in the original container to preserve product quality. It is safest to remove the medication directly from the packaged blister before taking it.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 114 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disorder
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute kidney failure
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia in men
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that excludes light, at a temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain its efficacy and prevents degradation.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu X 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.